Skip to content
Open access · CC-BY via OpenAlex

MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression

Danielle Yaron-Saminsky, Karthik Nagaraj, Rive Sarfstein, Zvi Laron, Metsada Pasmanik‐Chor, Haim Werner

International Journal of Molecular Sciences · 2021 · ▲ 3 citations

Abstract

The growth hormone (GH)-insulin-like growth factor-1 (IGF1) endocrine axis is a central player in normal growth and metabolism as well as in a number of pathologies, including cancer. The GH-IGF1 hormonal system, in addition, has emerged as a major determinant of lifespan and healthspan(definition). Laron syndrome (LS), the best characterized entity under the spectrum of the congenital IGF1 deficiencies, results from mutation of the GH receptor (GHR) gene, leading to dwarfism, obesity and other defects. Consistent with the key role of IGF1 in cellular proliferation, epidemiological studies have shown that LS patients are protected from cancer development. While reduced expression of components of the GH-IGF1 axis is associated with enhanced longevity in animal models, it is still unknown whether LS is associated with an increased lifespan. MicroRNAs (miRs) are endogenous short non-coding RNAs that regulate the expression of complementary mRNAs. While a number of miRs involved in the regulation of IGF components have been identified, no previous studies have investigated the differential expression of miRs in congenital IGF1 deficiencies. The present study was aimed at identifying miRs that are differentially expressed in LS and that might account for the phenotypic features of LS patients, including longevity. Our genomic analyses provide evidence that miR-132-3p was highly expressed in LS. In addition, we identified SIRT1, a member of the sirtuin family of histone deacetylases, as a target for negative regulation by miR-132-3p. The data was consistent with the notion that low concentrations of IGF1 in LS lead to elevated miR-132-3p levels, with ensuing reduction in SIRT1 gene expression. The impact of the IGF1-miR-132-3p-SIRT1 loop on aging merits further investigation.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/ijms222111861
Canonical
link ↗
Fetched
2026-10-23 MST

Cite this

APA
Yaron-Saminsky, D., Nagaraj, K., Sarfstein, R., Laron, Z., Pasmanik‐Chor, M., &amp; Werner, H. (2021). MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms222111861
Vancouver
Yaron-Saminsky D, Nagaraj K, Sarfstein R, Laron Z, Pasmanik‐Chor M, Werner H. MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression. International Journal of Molecular Sciences. 2021. doi:10.3390/ijms222111861.
BibTeX
@article{danielle2021MicroR, title = {MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression}, author = {Danielle Yaron-Saminsky and Karthik Nagaraj and Rive Sarfstein and Zvi Laron and Metsada Pasmanik‐Chor and Haim Werner}, journal = {International Journal of Molecular Sciences}, year = {2021}, doi = {10.3390/ijms222111861}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings